https://the483.com/health-ai-ehr-hipaa-six-laws/ The 483 en 2026-04-30T15:39:29.000Z Uploading Your EHR Voids HIPAA: Six Laws Fill the Gap https://the483.com/beone-buys-huahui-trispecific-option/ The 483 en 2026-04-30T14:47:47.000Z BeOne Buys $2B Option on Huahui Trispecific https://the483.com/abbvie-q1-15b-btk-degrader-cut/ The 483 en 2026-04-30T01:40:52.000Z AbbVie Posts $15B Q1, Drops ABBV-101 https://the483.com/ukraine-arrests-roblox-610k-theft/ The 483 en 2026-04-30T00:51:15.000Z Ukraine Arrests Three Over 610K Roblox Account Theft https://the483.com/oppfi-buys-bnc-bank-130m/ The 483 en 2026-04-29T23:23:31.000Z OppFi Buys Arizona Bank for $130M at 1.2x Book https://the483.com/adyen-talon-one-876m/ The 483 en 2026-04-29T22:24:44.000Z Adyen Bought Talon.One for $876M https://the483.com/lilly-deals-regeneron-otarmeni-fda/ The 483 en 2026-04-29T17:35:54.000Z Lilly Strikes $11.5B in Three Deals as Regeneron Clears Otarmeni https://the483.com/canada-crypto-atm-ban-bitcoin-depot/ The 483 en 2026-04-29T16:37:52.000Z Canada Moves to Ban Crypto ATMs After $704M Fraud Year https://the483.com/astrazeneca-q1-15b-80b-2030/ The 483 en 2026-04-29T15:44:23.000Z Posted $15.3B Q1, AstraZeneca Backs $80B 2030 Revenue Target https://the483.com/chiesi-kalvista-1-9b-deal/ The 483 en 2026-04-29T14:50:31.000Z Paid $1.9B: Chiesi Bought KalVista and Its Approved Drug https://the483.com/stericycle-cigarroa-patagonia-fcpa-trial/ The 483 en 2026-04-29T13:53:24.575Z Arrested in Patagonia, Stericycle Finance Chief Faces June 1 FCPA Trial https://the483.com/fda-real-time-trial-data-pilot/ The 483 en 2026-04-28T23:22:54.000Z FDA Debuts Real-Time Clinical Trial Data Pilot https://the483.com/shinyhunters-udemy-14m-extortion/ The 483 en 2026-04-28T22:24:30.000Z ShinyHunters Hits Udemy with 1.4M-Record Extortion Demand https://the483.com/vimeo-shinyhunters-anodot-breach/ The 483 en 2026-04-28T21:40:03.754Z Breached via Anodot, Vimeo Faces ShinyHunters' April 30 Ultimatum https://the483.com/abbvie-kestrel-kras-option/ The 483 en 2026-04-28T20:33:37.000Z AbbVie Buys $1.45B Option on Kestrel's KRAS Program https://the483.com/boehringer-survodutide-zepbound-gap/ The 483 en 2026-04-28T19:36:09.000Z Boehringer-Zealand Obesity Drug Posts 13.4%, Trails Zepbound https://the483.com/incyte-povorcitinib-vitiligo-approval/ The 483 en 2026-04-28T18:38:43.000Z Cleared 2 Phase 3 Trials, Incyte Plans Povorcitinib Vitiligo Filing https://the483.com/fda-amgen-tavneos-data-manipulation/ The 483 en 2026-04-28T17:37:15.000Z FDA Moves to Strip Amgen's $459M Tavneos Over Manipulated Data https://the483.com/scattered-spider-bouquet-6-counts/ The 483 en 2026-04-28T17:16:24.467Z Charged: Scattered Spider's 'Bouquet,' 19, Faces 6 Federal Counts